– USA, MN – Relievant Medsystems, a privately held medical device company transforming the treatment of Chronic Low Back Pain, today announced the appointment of Tyler Binney to its Board of Directors as President and CEO, replacing Arthur Taylor, who previously held the CEO position on an interim basis, and will return to his role on the Board of Directors.
“Tyler is a proven leader and has a long and successful history of bringing disruptive medical devices to market. We look forward to leveraging his experience accelerating growth through commercial execution, product innovation, and the building of strong, integrated teams,” said Executive Chairman, Richard Mott.
He added: “With an unparalleled level of clinical evidence supporting Intracept’s position in the CLBP care pathway and a Category I CPT code effective in January 2022, Relievant is poised for its next phase of growth and Tyler brings the right blend of experience and expertise to lead the Company at this important stage.”
About Tyler Binney
Mr. Binney brings more than 20 years of medical device leadership experience. He most recently served as President and General Manager of Interventional Urology at Teleflex. He had previously served as VP of Sales at NeoTract, Inc., which was acquired by Teleflex in 2017. Before his tenure at NeoTract, he served in multiple leadership roles in sales and marketing within two business units at Johnson & Johnson.
“I am excited to join the Relievant team at this important time, with a rapidly growing number of physicians recognizing that the Intracept procedure fills a well-established gap in the CLBP care pathway,” said Mr. Binney. “The Intracept procedure has been shown to deliver long-lasting improvements in pain and function for CLBP patients, with an objective biomarker that helps physicians identify those who may benefit from the procedure. I am excited to lead this team forward, continuing the successful commercialization achieved to date.”
About Relievant Medsystems
Relievant Medsystems is a privately held medical device company that is transforming the treatment of Chronic Low Back Pain with the Intracept Procedure – a novel, clinically proven, and commercially available treatment designed to improve the quality of life for the millions of patients suffering from CLBP from degenerative disc disease with Modic changes, a biomarker indicating that their pain is vertebrogenic in origin.
For more information: https://www.relievant.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.